NCT04082910 Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells Status UNKNOWN Phase PHASE1/PHASE2
NCT04079283 Radiomics of Immunotherapeutics Response Evaluation and Prediction Status COMPLETED Phase N/A
NCT04074967 Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04064359 Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors Status RECRUITING Phase PHASE1
NCT04059588 A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin Status COMPLETED Phase PHASE1
NCT04050709 QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers Status COMPLETED Phase PHASE1
NCT04047589 Assessing Exercise Behavior and Preferences Among Patients and Oncologists Status COMPLETED Phase N/A
NCT04046016 A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor Status COMPLETED Phase EARLY_PHASE1
NCT04035473 A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel Status COMPLETED Phase PHASE1
NCT04021277 PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin Status TERMINATED Phase PHASE1
NCT04013048 Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor Status COMPLETED Phase PHASE1
NCT03994211 Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer Status COMPLETED Phase PHASE1
NCT03993379 PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors Status TERMINATED Phase PHASE2